000 02920cam a2200325 a 4500
003 EG-GiCUC
008 190916s2019 ua d f m 000 0 eng d
040 _aEG-GiCUC
_beng
_cEG-GiCUC
041 0 _aeng
049 _aDeposite
097 _aPh.D
099 _aCai01.08.03.Ph.D.2019.En.A
100 0 _aEnas Shaaban Ali Ibrahim
245 1 0 _aAnalytical study of some drugs affecting the cardiovascular system /
_cEnas Shaaban Ali Ibrahim ; Supervised Maissa Yacuob Salim , Nagiba Yehia Mohammed , Yasmin Mohammed Fayez
246 1 5 _aدراسة تحليلية لبعض الادوية التى لها تأثير على القلب والاوعية الدموية
260 _aCairo :
_bEnas Shaaban Ali Ibrahim ,
_c2019
300 _a278 P. :
_bcharts ;
_c25cm
502 _aThesis (Ph.D.) - Cairo University - Faculty of Pharmacy - Department of Analytical Chemistry
520 _aThis thesis is dealing with the development of new analytical methods for determination of three drugs in both pure form and pharmaceutical formulations (Labetalol hydrochloride and Nebivolol hydrochloride) in combination with hydrochlorothiazide in presence of its main impurities and Tirofiban hydrochloride in presence of its in process impurity.The first method is derivative method for determination of drugs in presence of main impurities.The second method is first derivative of ratio spectra method which determines Labetalol and Nebivolol in binary mixtures with hydrochlorothiazide.The third method determined studied drugs in mixtures by ratio difference method. The fourth, fifth and sixth methods determined Labetalol and hydrochlorothiazide by dual wavelength, constant center and advanced absorbance subtraction methods. The seventh and eighth methods determined Nebivolol and hydrochlorothiazide by absorption factor and ratio subtraction methods. The ninth method based on the determination of Labetalol, Nebivolol and hydrochlorothiazide in presence of its main impurities by PLS and PCR mathematical modeling. The tenth method depends on mean centering of ratio spectra for determination of studied drugs in presence of impurities. The eleventh method was HPLC methods for simultaneous determination of studied drugs in their mixtures with its main impurities using different chromatographic conditions in pharmaceutical formulations and biological fluid for Tirofiban. The last method involves fabrication of two ion-selective membranes for determination of Labetalol hydrochloride with two different plasticizers
530 _aIssued also as CD
653 4 _aHydrochlorothiazide
653 4 _aLabetalol Hydrochloride
653 4 _aNebivolol Hydrochloride
700 0 _aMaissa Yacuob Salim ,
_eSupervisor
700 0 _aNagiba Yehia Mohammed ,
_eSupervisor
700 0 _aYasmin Mohammed Fayez ,
_eSupervisor
905 _aNazla
_eRevisor
905 _aShimaa
_eCataloger
942 _2ddc
_cTH
999 _c73897
_d73897